Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -31.85%240.13M | -49.19%199.91M | -33.65%224.65M | 12.08%1.36B | -23.08%276.06M | 21.83%352.36M | 40.86%393.43M | 17.87%338.58M | 108.97%1.21B | 47.65%358.89M |
| Cost of revenue | -10.73%580.12M | 122.84%649.84M | ||||||||
| Gross profit | 38.36%780.31M | 94.99%563.99M | ||||||||
| Operating expense | -41.18%173.13M | -53.94%138.06M | -41.40%158.48M | 22.10%488.59M | -24.98%202.73M | 6.57%294.32M | 21.68%299.75M | 3.86%270.46M | 19.72%400.15M | 572.53%270.24M |
| Staff costs | ---- | ---- | ---- | 34.14%270.6M | ---- | ---- | ---- | ---- | 41.31%201.72M | ---- |
| Selling and administrative expenses | ---- | ---- | ---- | -5.96%17.47M | ---- | ---- | ---- | ---- | -11.10%18.58M | ---- |
| -General and administrative expense | ---- | ---- | ---- | -5.96%17.47M | ---- | ---- | ---- | ---- | -11.10%18.58M | ---- |
| Rent and land expenses | ---- | ---- | ---- | -55.64%11.92M | ---- | ---- | ---- | ---- | 41.33%26.87M | ---- |
| Other operating expenses | -41.11%173.39M | -54.19%138.16M | -40.95%159.88M | 23.56%189.51M | -24.84%203.18M | 6.57%294.44M | 22.36%301.61M | 3.81%270.77M | 0.93%153.37M | 212.40%270.34M |
| Total other operating income | 108.00%260K | -94.78%97K | 350.32%1.4M | 135.51%902K | 331.73%449K | 6.84%125K | 1,173.97%1.86M | -26.89%310K | 1.06%383K | 115.69%104K |
| Operating profit | 15.44%67.01M | -33.98%61.85M | -2.86%66.17M | 78.06%291.72M | -17.28%73.33M | 344.52%58.05M | 184.09%93.68M | 153.78%68.12M | 464.10%163.83M | 925.16%88.65M |
| Net non-operating interest income (expenses) | 82.30%-1.9M | 78.30%-2.04M | 73.04%-2.51M | 35.42%-27.14M | 62.41%-3.81M | 0.76%-10.71M | 17.55%-9.41M | 23.57%-9.31M | -47.99%-42.03M | -23.86%-10.12M |
| Non-operating interest income | ---- | ---- | ---- | 71.50%6.88M | ---- | ---- | ---- | ---- | 16.75%4.01M | ---- |
| Non-operating interest expense | -82.30%1.9M | -78.30%2.04M | -73.04%2.51M | -26.10%34.03M | -62.41%3.81M | -0.76%10.71M | -17.55%9.41M | -23.57%9.31M | 44.62%46.04M | -12.81%10.12M |
| Net investment income | -14.28%1.18M | -19.79%1.5M | 24.44%1.66M | 448.09%2.92M | 77.36%2.3M | 52.82%1.38M | 66.52%1.88M | 64.89%1.33M | 82.94%-838K | 116.84%1.29M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 87.50%105K | -14.58%41K | -83.02%9K | 127.96%212K | 16.33%57K | 343.48%56K | 11.63%48K | 120.83%53K | -40.00%93K | 16.67%49K |
| Special income (charges) | -330.86%-1.05M | 93.85%-243K | ||||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | 539.01%5.93M | ---- | ---- | ---- | ---- | 93.74%928K | ---- |
| Less:Other special charges | ---- | ---- | ---- | -6,237.50%-1.47M | ---- | ---- | ---- | ---- | --24K | ---- |
| Less:Write off | ---- | ---- | ---- | -380.96%-3.41M | ---- | ---- | ---- | ---- | -120.41%-709K | ---- |
| Other non-operating income (expenses) | -9.78%369K | 22.46%409K | ||||||||
| Income before tax | 36.14%66.4M | -28.82%61.35M | 8.53%65.33M | 120.27%267.03M | -10.00%71.88M | 1,450.72%48.77M | 279.24%86.19M | 288.55%60.19M | 248.25%121.23M | 840.38%79.87M |
| Income tax | 177.83%16.24M | -53.31%10.91M | -4.95%12.72M | 173.34%59.32M | 26.86%16.72M | 202.85%5.85M | 339.13%23.38M | 954.45%13.38M | 16.48%21.7M | -13.36%13.18M |
| Net income | 16.85%50.16M | -19.71%50.44M | 12.39%52.61M | 108.70%207.71M | -17.29%55.16M | 3,432.92%42.93M | 260.92%62.81M | 229.14%46.81M | 199.13%99.53M | 356.47%66.68M |
| Net income continuous operations | 16.85%50.16M | -19.71%50.44M | 12.39%52.61M | 108.70%207.71M | -17.29%55.16M | 3,432.92%42.93M | 260.92%62.81M | 229.14%46.81M | 199.13%99.53M | 356.47%66.68M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 16.85%50.16M | -19.71%50.44M | 12.39%52.61M | 108.70%207.71M | -17.29%55.16M | 3,432.92%42.93M | 260.92%62.81M | 229.14%46.81M | 199.13%99.53M | 356.47%66.68M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 16.85%50.16M | -19.71%50.44M | 12.39%52.61M | 108.70%207.71M | -17.29%55.16M | 3,432.92%42.93M | 260.92%62.81M | 229.14%46.81M | 199.13%99.53M | 356.47%66.68M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 17.31%0.0061 | -19.74%0.0061 | 12.28%0.0064 | 109.09%0.0253 | -17.28%0.0067 | 5,100.00%0.0052 | 261.90%0.0076 | 235.29%0.0057 | 199.18%0.0121 | 361.29%0.0081 |
| Diluted earnings per share | 17.31%0.0061 | -19.74%0.0061 | 12.28%0.0064 | 109.09%0.0253 | -17.28%0.0067 | 5,100.00%0.0052 | 261.90%0.0076 | 235.29%0.0057 | 199.18%0.0121 | 361.29%0.0081 |
| Dividend per share | 0 | 300.00%0.01 | 0 | 0.005 | 0.0025 | 0 | 0.0025 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.